Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

AbCellera (NASDAQ:ABCL) Falls 9% in Pre-Market After $200 Million Stock Offering

AbCellera (NASDAQ:ABCL) shares were trading at $8.91 in pre-market activity on August 12, 2026, down 8.71% from the prior close of $9.76. The decline follows the company's announcement of a $200 million underwritten public offering of common shares and pre-funded warrants, disclosed after the …

Nitish Kishor | 12 August 2026

Why Is Absci (NASDAQ:ABSI) Stock Down 8% in Pre-Market Despite Positive Trial Data?

Absci (NASDAQ:ABSI) shares were trading at $8.70 in pre-market activity on August 12, 2026, down 7.55% from the prior close of $9.41. Shares had gained 4.44% during the prior regular session, but slid in extended and pre-market trading as investors weighed the company's second …

Nitish Kishor | 12 August 2026

Liquidia (NASDAQ:LQDA) Rises 4% in Pre-Market Ahead of Q2 2026 Earnings

Liquidia (NASDAQ:LQDA) shares were trading at $91.91 in pre-market activity on August 12, 2026, up 4.38% from the prior close of $88.05. The move comes ahead of the company's second quarter fiscal 2026 earnings report, scheduled for release before market open the same day.

Nitish Kishor | 12 August 2026

Wave Life Sciences (NASDAQ:WVE) Penny Stock Climbs 7% in Pre-Market as Biotech Sector Rebounds

Wave Life Sciences (NASDAQ:WVE) shares were trading at $5.38 in pre-market activity on August 12, 2026, up 6.64% from the prior close of $5.05. The move follows a prior-session slide to a fresh 52-week low near $5.01, with shares having fallen roughly 25% over …

Nitish Kishor | 12 August 2026

Zura Bio (NASDAQ:ZURA) Shares Rise 4% in Pre-Market After Enrollment Milestones

Zura Bio (NASDAQ:ZURA) shares were trading at $5.79 in pre-market activity on August 12, 2026, up 4.14% from the prior close of $5.56. The prior session's close had come in slightly lower, down 1.24%, even as the company reported second quarter 2026 results and …

Nitish Kishor | 12 August 2026

Cigna (NYSE:CI) Shares Trading Lower Amid Broad Health Insurer Selloff

Cigna (NYSE:CI) shares are trading down 2.17% intraday to $272.36, from a prior close of $278.40. The decline comes as billionaire investor Mark Cuban publicly urged shareholders to pressure major insurers, including Cigna, UnitedHealth (NYSE:UNH), CVS (NYSE:CVS), Elevance (NYSE:ELV), Humana (NYSE:HUM), and Centene (NYSE:CNC), …

Nitish Kishor | 11 August 2026

Elevance Health (NYSE:ELV) Trading Down as Mark Cuban Pressures Health Insurers

Elevance Health (NYSE:ELV) shares are trading down 2.00% intraday to $389.73, from a prior close of $397.70. The decline comes as billionaire investor Mark Cuban publicly urged shareholders to pressure insurers, including Elevance, UnitedHealth (NYSE:UNH), CVS (NYSE:CVS), Cigna (NYSE:CI), Humana (NYSE:HUM), and Centene (NYSE:CNC), …

Nitish Kishor | 11 August 2026

GeneDx Holdings (NASDAQ:WGS) Trading Up 6% on New Testing Platform Launch

GeneDx Holdings (NASDAQ:WGS) shares are trading up 6.05% intraday to $82.59, from a prior close of $77.88. The move follows the company's announcement of a new online offering designed to expand accessibility of exome testing at scale for pediatric patients with global developmental delay, …

Nitish Kishor | 11 August 2026

Why Is Humana (NYSE:HUM) Stock Trading Down Today?

Humana (NYSE:HUM) shares are trading down 2.89% intraday to $374.58, from a prior close of $385.70. The decline comes as billionaire investor Mark Cuban publicly urged institutional investors to divest from major carriers, including Humana, Cigna (NYSE:CI), Elevance (NYSE:ELV), CVS (NYSE:CVS), and Centene (NYSE:CNC), …

Nitish Kishor | 11 August 2026

Intelligent Bio Solutions (NASDAQ:INBS) Penny Stock Trading Up 5% on FDA Study Completion

Intelligent Bio Solutions (NASDAQ:INBS) shares are trading up 5.10% intraday to $2.06, from a prior close of $1.96. The move follows the company's announcement that it has completed its multi-site Method Comparison Study for the Intelligent Fingerprinting Drug Screening System, one of several studies …

Nitish Kishor | 11 August 2026
Support

Hi! How can we help you today?

Loading…